Science Current Events | Science News | Brightsurf.com
 

Molecular imaging holds promise for early intervention in common uterine cancer

October 01, 2009
Combined molecular imaging technique effectively evaluates and predicts tumor's course

Reston, Va.-A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. This research was presented in a study published in the October issue of The Journal of Nuclear Medicine.

"Endometrial carcinoma is one of the most common female malignant tumors," says Hidehiko Okazawa, M.D., Ph.D., professor in the division of medical imaging at the biomedical imaging research center at the University of Fukui in Japan and one of the lead researchers of the study. "The method of positron emission tomography (PET) imaging we used in the study is noninvasive, and it has tremendous potential to save women with endometrial carcinoma from undergoing unnecessary operations and biopsies that could sabotage their reproductive potential."

If the disease is caught early enough, the five-year survival rate is higher than 90% for patients with endometrial carcinoma. PET imaging may provide physicians with a tool that lets them recognize the extent of the disease before it reaches advanced stages.

This study shows that PET is a promising molecular imaging technique for personalized therapy. Molecular imaging and nuclear medicine provide the possibility of determining the invasiveness and aggressiveness of malignant tumors in the uterus earlier on, before disease progresses. With this technique, physicians gain the advantage of a more precise diagnosis along with the ability to better predict the tumor's growth patterns and plan for the most appropriate therapeutic treatment strategy.

"The article in the JNM from Dr. Tsujikawa and colleagues provides an example of the unique capacity of molecular imaging to measure in vivo cancer biology," says David A. Mankoff, M.D., Ph.D., professor of radiology, medicine and bioengineering at the University of Washington and Seattle Cancer Care Alliance in Seattle. "Most notably, it shows how imaging multiple facets of tumor phenotype-in this case, estrogen receptor expression and glucose metabolism-can provide insight into the clinical behavior of cancer. The broad implication of this study, and other similar studies that have tested PET and molecular imaging to characterize cancer characteristics, is that imaging can help direct cancer patients toward optimized, individualized treatments."

In the study, the researchers used a specialized form of PET imaging called "estrogen receptor expression imaging" for 22 patients with endometrial adenocarcinoma and nine patients with endometrial hyperplasia (a thickening of the uterine lining that is a risk factor for developing endometrial cancer) to evaluate diagnostic accuracy. All patients underwent preoperative PET scans with 18F-fluoroestradiol (18F-FES)-a tracer that has been successfully used in diagnosing breast cancer-and 18F-fluorodeoxyglucose (18F-FDG) to compare differences in tracer accumulation.

The researchers confirmed that endometrial carcinoma reduces estrogen dependency with accelerated glucose metabolism as it progresses to a higher stage or grade. By combining the two tracers, researchers were able to use a new index of uptake ratio that can better predict pathologic stages and aggressiveness of tumors. The results of the study were encouraging, with the combined techniques having 86% accuracy.

For endocrine-related tumors (including endometrial cancer), tumors vary from well-differentiated and close in character to the tissue of origin to poorly differentiated tumors, which are aggressive and bear less resemblance to the tissue of origin. The well-differentiated tumors tend to be more slow-growing and less aggressive than poorly differentiated tumors. They also retain their endocrine function and/or responsiveness.

For endometrial cancer, estrogen receptor expression is related to endocrine responsiveness and indicated by FES uptake. Poorly differentiated tumors often have increased and abnormal breakdown of glucose, indicated by FDG. The combination of the two, as indicated by the study, was better than either alone at indicating the aggressiveness of the tumor.

Personalized cancer therapy involves treatment that is individualized for patients based on patient characteristics and the tumor's biology. By studying the tumor's properties, physicians can predict the tumor's path and formulate the best strategy for treating the disease.

Society of Nuclear Medicine


Related Endometrial Carcinoma Current Events and Endometrial Carcinoma News Articles


Aromatase inhibitors increased risk of heart disease in postmenopausal women with breast cancer
Postmenopausal women who take aromatase inhibitors as a treatment for breast cancer may be at an increased risk for developing cardiovascular disease, according to the results of a meta-analysis.

New research findings may enable earlier diagnosis of uterine cancer
Cancer is a genetic disease. It occurs when changes take place in the genes that regulate cell division, cell growth, cell death, cell signalling and blood vessel formation - either due to mutations caused by external factors such as smoking or radiation - or due to inherited changes.
More Endometrial Carcinoma Current Events and Endometrial Carcinoma News Articles

Advances in Surgical Pathology: Endometrial Carcinoma

Advances in Surgical Pathology: Endometrial Carcinoma
by Anna Sienko MD (Author)


Part of the popular Advances in Surgical Pathology Series, this volume is a concise, updated review of the pathological characteristics of endometrial cancer. It emphasizes the histologic correlation, clinical management, and treatment of endometrial cancer, and features current and emerging concepts in the field. The book provides a resource for the timely updates in knowledge that are necessary for daily practice, for current credentialing, and for the self-assessment modules for recertification (MOC).

A free companion web site features fully searchable text as well as over 130 full-color images.

Endometrial Carcinoma

Endometrial Carcinoma
by Shen-yi Li (Author), En-yu Wang (Author), Shen-yi Li (Translator), En-yu Wang (Translator), Michihiro Seta (Translator)


During the past 20 years, endometrial carcinoma has continued to increase in frequency and it is quite possible that this carcinoma will become the major gynecologic malignancy in the future. For many years, endometrial carcinoma was considered less malignant than other gynecologic malignancies, simple hysterectomy and bil­ ateral salpingo-oophorectomy or surgery combined with radiation being effective in certain circumstances. It is unfortunate to note that the global 5-year survival rate for patients with advanced or recurrent endometrial carcinoma has improved only slightly. Therefore any complacency regarding this 'benign malignancy' should be reconsidered. There is a growing awareness of the nature of end­ ometrial carcinoma, with advances in our knowledge ranging from its etiology...

First Aid for the USMLE Step 1 2014 (First Aid Series)

First Aid for the USMLE Step 1 2014 (First Aid Series)
by Tao Le (Author), Vikas Bhushan (Author)


The world's bestselling medical review book--with more than 1,250 frequently tested facts and mnemonics An unmatched collection of 1,250+ must-know facts and mnemonics provide a complete framework for your USMLE review Updates and new facts based on the largest student survey in First Aid history 350+ color clinical photographs with new arrows and captions New composite diagrams integrate complex concepts for easy memorization Updated rapid-review section for last-minute cramming Expanded faculty review process with nationally known USMLE instructors Free real-time updates and corrections at www.firstaidteam.com

Mutational Analysis of p53 gene and dietary risk factors: p53 gene for developing targeted pharmaceutical products and dietary approaches to treat endometrial carcinoma

Mutational Analysis of p53 gene and dietary risk factors: p53 gene for developing targeted pharmaceutical products and dietary approaches to treat endometrial carcinoma
by Nasir Ali (Author), Umar Bacha (Author), Javed Muhammad (Author)


Endometrial carcinoma is one of the most common malignancies in the female genital tract and poses serious health hazards. The gene P53 safeguards cell integrity however; a mutation in this gene increases the lifeline of the cells which are programmed for cell death. This particular gene participates in many human cancers including endometrial, ovarian and tubal carcinomas. In this study we screened exon 5 of p53 gene to find out whether this exon is a hotspot for mutations or not. We evaluated (n=45) samples of endometrial carcinoma and (n=45) controls from a local population. However, we were unable to find any nucleotide alteration in exon 5. It appears, therefore, exon 5 of p53 is not a hot spot for mutation in local population based on recent our findings.

Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach

Diagnosis of Endometrial Biopsies and Curettings: A Practical Approach
by Michael Mazur (Author), Robert J. Kurman (Author)


Derived from the authors' long-running course presented at the International Academy of Pathology, this second edition, now with color illustrations, continues the tradition of its predecessor as being the concise and complete diagnostic guide to the endometrial biopsy. The text is structured so as to present a logical approach to formulating a pathologic diagnosis from the diverse array of tissue received in the surgical pathology laboratory. Color illustrations show typical artifacts and distortion, and explain their impact on diagnostic interpretation. Each chapter includes a section summarizing the features that must be discussed in the final pathology report.

Physical Examination and Health Assessment, 6th Edition

Physical Examination and Health Assessment, 6th Edition
by Carolyn Jarvis (Author)


With an easy-to-read approach and unmatched learning support, Physical Examination & Health Assessment, 6th Edition offers a clear, logical, and holistic approach to physical exam across the lifespan. Detailed illustrations, summary checklists, and new learning resources ensure that you learn all the skills you need to know. This gold standard in physical exam reflects what is going on in nursing today with coverage of emerging trends and new evidence-based content. It's easy to see why this text is, far and away, #1 in this market! This item is a stand-alone text.A clear, conversational writing style makes learning easier.A two-column format distinguishes normal findings from abnormal findings, and uses color, step-by-step photos to clarify examination techniques and expected...

First Aid for the USMLE Step 2 CK, Eighth Edition (First Aid USMLE)

First Aid for the USMLE Step 2 CK, Eighth Edition (First Aid USMLE)
by Tao Le (Author), Vikas Bhushan (Author), Nathan Skelley (Author)


An indispensable high-yield review for the USMLE Step 2 CK! The eighth edition of First Aid for the USMLE Step 2 CK is written by medical students who successfully passed the exam and reviewed by top faculty. The result is proven information and strategies that maximize your study time and deliver the results you want! Features:
Thousands of must-know facts that summarize frequently tested topics Completely updated based on feedback from students who passed 120+ photographs similar to those on the exam Full-color design includes numerous clinical images Rapid Review section for last-minute cramming Updated ratings of Step 2 CK review resources

Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 9th Edition

Medical-Surgical Nursing: Assessment and Management of Clinical Problems, 9th Edition
by Sharon L. Lewis (Author), Shannon Ruff Dirksen (Author), Margaret McLean Heitkemper (Author), Linda Bucher (Author)


Over the past three decades, more and more nursing educators have turned to Lewis: Medical-Surgical Nursing for its accurate and up-to-date coverage of the latest trends, hot topics, and clinical developments in the field of medical-surgical nursing - and the new ninth edition is no exception! Written by a dedicated team of expert authors led by Sharon Lewis, Medical-Surgical Nursing, 9th Edition offers the same easy-to-read style that students have come to love, along with the timely and thoroughly accurate content that educators have come to trust. Completely revised and updated content explores patient care in various clinical settings and focuses on key topics such as prioritization, critical thinking, patient safety, and NCLEX® exam preparation. Best of all - a complete collection...

Cell and Molecular Biology of Endometrial Carcinoma

Cell and Molecular Biology of Endometrial Carcinoma
by Hiroyuki Kuramoto (Editor), M. Nishida (Editor)


The 15th International Symposium of the Japan Human Cell Society on Cell and Molecular Biology of Endometrial Carcinoma brought together leading researchers from Japan and around the world. The papers collected here are the work of twenty-two leaders in their field and are organized in ten major categories. The first section, in vitro experimental systems, takes up the pioneering work by Kuramoto in 1968 and Nishida in 1980 in establishing, respectively, the HEC-1 and hormone-responsive endometrial carcinoma cell lines. Other topics include apoptosis, proliferation, and growth factors; cell cycle regulators; signaling pathways; angiogenesis; carcinogenesis; hormones and hormone receptors; genes and gene expression; endometrial receptivity; and chemo-resistance and -sensitivity. Presenting...

© 2014 BrightSurf.com